Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, overdose rescue, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in Richmond, Virginia.
Industry, Sector and Symbol
Stock Exchange LON
Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
SymbolLON:INDV
CUSIPN/A
Phone+44-1753-217800
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-54.72%
Return on EquityN/A
Return on Assets-41.38%
Miscellaneous
EmployeesN/A
Outstanding Shares721,460,000
Market Cap£2,930.00
Indivior (LON:INDV) Frequently Asked Questions
What is Indivior's stock symbol?
Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."
What price target have analysts set for INDV?
6 analysts have issued 12-month price targets for Indivior's shares. Their forecasts range from GBX 365 to GBX 600. On average, they anticipate Indivior's share price to reach GBX 476.33 in the next twelve months. This suggests a possible upside of 42.0% from the stock's current price. View Analyst Ratings for Indivior.
What is the consensus analysts' recommendation for Indivior?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Indivior's key competitors?
Some companies that are related to Indivior include Smith & Nephew (SN), Henry Schein (HSIC), WellCare Health Plans (WCG), Hologic (HOLX), Seattle Genetics (SGEN), Cochlear (COH), Alnylam Pharmaceuticals (ALNY), Jazz Pharmaceuticals (JAZZ), Universal Health Services, Inc. Class B (UHS), Varian Medical Systems (VAR), Genmab A/S (GNMSF), WILLIAM DEMANT/ADR (WILYY), STRAUMANN Hldg/ADR (SAUHY), Perrigo (PRGO) and DENTSPLY SIRONA (XRAY).
Who are Indivior's key executives?
Indivior's management team includes the folowing people:
- Mr. Shaun Thaxter, CEO & Exec. Director
- Mr. Mark Crossley, CFO & Exec. Director
- Dr. Christian Heidbreder, Chief Scientific Officer
- Mr. Ingo Elfering, Chief Information & Innovation Officer
- Mr. Javier Rodriguez, Chief Legal Officer
Has Indivior been receiving favorable news coverage?
News stories about INDV stock have been trending somewhat positive this week, according to Accern Sentiment. The research group scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Indivior earned a news sentiment score of 0.21 on Accern's scale. They also gave headlines about the specialty pharmaceutical company an impact score of 44.77 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Indivior?
Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Indivior's stock price today?
One share of INDV stock can currently be purchased for approximately GBX 335.40.
How big of a company is Indivior?
Indivior has a market capitalization of £2.93 billion.
How can I contact Indivior?
Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.
MarketBeat Community Rating for Indivior (LON INDV)
MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe INDV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INDV will underperform the S&P 500 over the long term. You may vote once every thirty days.
